ATS 2019 Virtual Final Program

114 Baseline Characteristics of All Patients Randomized in a Phase IIb Trial of Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis and Risk of Pulmonary Hypertension/ J. Behr, S.D. Nathan, S. Harari, W. Wuyts, N. Mogulkoc Bishop, D.E. Bouros, K. Antoniou, J. Guiot, M. Kramer, K.-U. Kirchgaessler, M. Bengus, F. Gilberg, A.U. Wells, Munchen, Germany, p.A4092 115 Evaluating the Role of Support Group Participation on Palliative Care Referral and Mortality in Idiopathic Pulmonary Fibrosis/ R.H. Zou, S.M. Nouraie, M.Q. Rosenzweig, X. Chen, N. Kaminski, K.F. Gibson, D.J. Kass, K.O. Lindell, Pittsburgh, PA, p.A4093 116 Rates of Adherence and Persistence of Antifibrotic Therapies in the U.S. Medicare Population/ M. Corral, S. Reddy, E. Chang, M. Broder, S. Gokhale, K. Raimundo, South San Francisco, CA, p.A4094 117 Endobronchial Valves for Management of Persistent Air Leaks in Diffuse Parenchymal Lung Disease/ R.G. Valentin, J. Jaber, D.C. Gomez Manjarres, D.C. Patel, Gainesville, FL, p.A4095 118 A World Cafe Approach to Palliative Care and Planning for the Future in Fibrotic Lung Disease/ A.-M. Russell, A. Shone, M. Love, D. Shanagher, I. Byrne, L. Fox, B. Korn, A.M. Doyle, N. Cassidy, London, United Kingdom, p.A4096 119 Treatment with Antifibrotic Agents in Pleuroparenchymal Fibroelastosis with Usual Interstitial Pneumonia/ K. Sugino, Y. Nakamura, H. Shimizu, K. Matsumoto, M. Ando, K. Mori, E. Tsuboi, S. Homma, Tokyo, Japan, p.A4097 120 Improving Advance Care Planning for People with IPF/ M. Kalluri, D. Laverty, K. Whitfield, Edmonton, Canada, p.A4098 CLINICAL RAPID: RAPID ABSTRACT POSTER DISCUSSION SESSION B104 CRITICAL CARE: CATCH-22 - BEYOND THE VENTILATOR: THE CHALLENGES OF DELIRIUM, ICU-ACQUIRED WEAKNESS, AND REHABILITATION 2:15 p.m. - 4:15 p.m. OMNI DALLAS DOWNTOWN Trinity Ballroom 1-3 (Level 3) Abstract Summaries 2:15-2:45 Viewing/Discussion 2:45-4:15 Chairing: D.C. Files, MD, Winston-Salem, NC T.D. Girard, MD, MSci, Pittsburgh, PA D.K. Costa, PhD, RN, Ann Arbor, MI 901 Delirium... “Unable-to-Assess”? An Electronic Health Record-Based Evaluation of Inappropriate “Unable-to-Assess” Confusion Assessment Method for the Intensive Care Unit (ICU) Documentation in a Medical ICU/ O. Awan, R.G. Buhr, B.B. Kamdar, Los Angeles, CA, p.A4099 902 Understanding “Unclassified” Delirium: A Post-Hoc Analysis of the Brain-ICU Cohort/ E. Nuzzo, P.P. Pandharipande, J.C. Jackson, E.W. Ely, T.D. Girard, Pittsburgh, PA, p.A4100 903 Decreasing Delirium Through Music (DDM): A Randomized Controlled Feasibility Trial/ S.H. Khan, R. Purpura, S. Durrani, S. Wang, H. Lindroth, J. Meeker, P. Hanneman, C. Xu, B.A. Khan, Indianapolis, IN, p.A4101 904 Predictors of Higher-Level Mobility in ICU Patients with Delirium/ L.P. Clark, C.T.L. Hough, M.A. Weinreich, S.E. Jolley, New Orleans, LA, p.A4102 905 Comparison of Haloperidol Versus Aripiprazole for Delirium Management in a Medical Intensive Care Unit at a Tertiary Care Center/ B.E. DiSilvio, S. Baltaji, L. Finoli, A.S. Shah, K. Malik, Pittsburgh, PA, p.A4103 906 The Effects of CAM-ICU Verbal Reporting During Academic Rounds on ICU Mortality and Length of Stay/ D. Blackwood, B. Duchenne, M. Brown, K.B. Brownell, M. Gosnell, F. Gregoire, Baltimore, MD, p.A4104 907 The Use of Melatonin to Prevent Delirium in the Critically Ill Elderly/ M. Forte, J. Gordon, A. Patel, M. Harris, Pueblo, CO, p.A4105 908 Relationship of Level of Consciousness in Critical Illness with Disability and Quality of Life/ M. Mart, J. Thompson, E.W. Ely, P. Pandharipande, M. Patel, J.E. Wilson, S. Williams Roberson, R. Chandrasekhar, N.E. Brummel, Nashville, TN, p.A4106 909 Results of a Respiratory Therapist Driven Weaning Protocol Combined with Early Mobility in a Long Term Acute Care Hospital/ J. Stienecker, M. Komarek, D. Rampe, Lima, OH, p.A4107 910 Early Rehabilitation in Patients Requiring Continuous Renal Replacement Therapy Is Safe and Feasible: A Quality Improvement Initiative/ K. Mayer, A.R. Hornsby, J.T. Cunningham, H. Yuan, C. Hauschild, P.E. Morris, J.A. Neyra, Lexington, KY, p.A4108 911 The Efficacy and Safety of Leg Cycle Ergometry in Critically Ill Adults: A Systematic Review and Meta-Analysis/ A. Takaoka, R. Utgikar, B. Rochwerg, D.J. Cook, M. Kho, Hamilton, Canada, p.A4109 912 Application of a Mobility Intervention Bundle to Improve Early Mobility Practices of Critically Ill Patients/ C.J. Ellison, W.D. Schweickert, A. Liou, K. Kellner, V. Golightly, P.E. Morris, D.C. Files, R. Bakhru, Winston-Salem, NC, p.A4110 913 Understanding Variability in Mobility Practices: Do Higher Performing Hospitals Mobilize More Complex Patients?/ M. Weinreich, E. Caldwell, S.E. Jolley, S. Lokhandwala, C.T.L. Hough, Seattle, WA, p.A4111 914 Physical Rehabilitation Core Outcomes in Critical Illness: A Modified Delphi Consensus Study to Establish a Core Outcome Set/ B. Connolly, M. Barclay, E. Corner, C. Davies, N. Hart, N. Pattison, G. Sturmey, L. Denehy, D.M. Needham, P. Williamson, B. Blackwood, London, United Kingdom, p.A4112 915 Improved Outcomes in Real World Settings: The Effect of ABCDE Bundle Delivery at Community Hospitals/ J. DeMellow, P. Romano, C. Drake, M. Balas, T.Y. Kim, Stockton, CA, p.A4113 916 Relationship Between Baseline Muscle Mass and ICU-Acquired Weakness Upon Hospital Discharge in Critically Ill Mechanically Ventilated Patients/ K.S. Wolfe, D. Meza, K. Dugan, A. Pohlman, J.B. Hall, J.P. Kress, J. Chung, B.K. Patel, Chicago, IL, p.A4114 ATS 2019 • Dallas, TX 210 MONDAY • MAY 20